MX2017007635A - Metodos de produccion de polipeptidos de hormona de crecimiento modificada por ctp de accion prolongada. - Google Patents
Metodos de produccion de polipeptidos de hormona de crecimiento modificada por ctp de accion prolongada.Info
- Publication number
- MX2017007635A MX2017007635A MX2017007635A MX2017007635A MX2017007635A MX 2017007635 A MX2017007635 A MX 2017007635A MX 2017007635 A MX2017007635 A MX 2017007635A MX 2017007635 A MX2017007635 A MX 2017007635A MX 2017007635 A MX2017007635 A MX 2017007635A
- Authority
- MX
- Mexico
- Prior art keywords
- growth hormone
- methods
- long acting
- producing long
- modified growth
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 102000002265 Human Growth Hormone Human genes 0.000 abstract 1
- 108010000521 Human Growth Hormone Proteins 0.000 abstract 1
- 239000000854 Human Growth Hormone Substances 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6437—Coagulation factor VIIa (3.4.21.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/644—Coagulation factor IXa (3.4.21.22)
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/06—Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
- G06Q10/063—Operations research, analysis or management
- G06Q10/0633—Workflow analysis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/06—Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
- G06Q10/063—Operations research, analysis or management
- G06Q10/0637—Strategic management or analysis, e.g. setting a goal or target of an organisation; Planning actions based on goals; Analysis or evaluation of effectiveness of goals
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/06—Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
- G06Q10/063—Operations research, analysis or management
- G06Q10/0639—Performance analysis of employees; Performance analysis of enterprise or organisation operations
- G06Q10/06393—Score-carding, benchmarking or key performance indicator [KPI] analysis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/02—Marketing; Price estimation or determination; Fundraising
- G06Q30/0201—Market modelling; Market analysis; Collecting market data
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21022—Coagulation factor IXa (3.4.21.22)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Business, Economics & Management (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Human Resources & Organizations (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Strategic Management (AREA)
- Biotechnology (AREA)
- Entrepreneurship & Innovation (AREA)
- Economics (AREA)
- Development Economics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Educational Administration (AREA)
- Marketing (AREA)
- General Business, Economics & Management (AREA)
- Theoretical Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Game Theory and Decision Science (AREA)
- Reproductive Health (AREA)
- Tourism & Hospitality (AREA)
- Finance (AREA)
- Accounting & Taxation (AREA)
- Operations Research (AREA)
Abstract
Se describe en la presente un método para fabricar una hormona de crecimiento humano recombinante (hGH) modificada por una extensión CTP en un sistema de cultivo de células de mamífero.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462090104P | 2014-12-10 | 2014-12-10 | |
US201462090116P | 2014-12-10 | 2014-12-10 | |
US201462090124P | 2014-12-10 | 2014-12-10 | |
PCT/IL2015/051196 WO2016092549A1 (en) | 2014-12-10 | 2015-12-10 | Methods of producing long acting ctp-modified growth hormone polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017007635A true MX2017007635A (es) | 2017-09-11 |
Family
ID=56106835
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017007635A MX2017007635A (es) | 2014-12-10 | 2015-12-10 | Metodos de produccion de polipeptidos de hormona de crecimiento modificada por ctp de accion prolongada. |
MX2017007634A MX2017007634A (es) | 2014-12-10 | 2015-12-10 | Métodos para producir polipéptidos modificados por ctp de acción prolongada. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017007634A MX2017007634A (es) | 2014-12-10 | 2015-12-10 | Métodos para producir polipéptidos modificados por ctp de acción prolongada. |
Country Status (22)
Country | Link |
---|---|
US (3) | US20160168588A1 (es) |
EP (4) | EP4212546A1 (es) |
KR (3) | KR20200118505A (es) |
CN (1) | CN107438623B (es) |
AU (2) | AU2015358890B2 (es) |
CO (1) | CO2017006870A2 (es) |
EA (1) | EA201791275A1 (es) |
ES (1) | ES2943359T3 (es) |
HK (2) | HK1243444A1 (es) |
HR (1) | HRP20230405T8 (es) |
IL (2) | IL252778B (es) |
MX (2) | MX2017007635A (es) |
NZ (1) | NZ733113A (es) |
PE (1) | PE20171380A1 (es) |
PH (1) | PH12017501089A1 (es) |
PL (1) | PL3230309T3 (es) |
RU (2) | RU2021103436A (es) |
SG (1) | SG11201704706RA (es) |
SI (1) | SI3230309T1 (es) |
TW (2) | TW202231657A (es) |
WO (2) | WO2016092549A1 (es) |
ZA (1) | ZA201704595B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9249407B2 (en) | 2006-02-03 | 2016-02-02 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
US10221228B2 (en) | 2006-02-03 | 2019-03-05 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
US20140113860A1 (en) | 2006-02-03 | 2014-04-24 | Prolor Biotech Ltd. | Long-acting polypeptides and methods of producing and administering same |
US9663778B2 (en) | 2009-07-09 | 2017-05-30 | OPKO Biologies Ltd. | Long-acting coagulation factors and methods of producing same |
US20150158926A1 (en) | 2013-10-21 | 2015-06-11 | Opko Biologics, Ltd. | Long-acting polypeptides and methods of producing and administering same |
EP4212546A1 (en) | 2014-12-10 | 2023-07-19 | OPKO Biologics Ltd. | Methods of producing long acting ctp-modified polypeptides |
IL301728A (en) | 2015-06-19 | 2023-05-01 | Opko Biologics Ltd | Long-term coagulation factors and methods for their preparation |
BR112019000610A2 (pt) * | 2016-07-11 | 2019-07-02 | Opko Biologics Ltd | fator vii de coagulação de longa ação e métodos de produção do mesmo |
RU2652884C1 (ru) * | 2016-11-25 | 2018-05-03 | Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства | Штамм клеток яичников китайского хомячка сно-еро 4а9 - продуцент высокосиалированного эритропоэтина |
US20200262887A1 (en) * | 2018-11-30 | 2020-08-20 | Opko Ireland Global Holdings, Ltd. | Oxyntomodulin peptide analog formulations |
WO2021005604A1 (en) * | 2019-07-11 | 2021-01-14 | Opko Biologics Ltd. | Long-acting igf-1 or igf-1 variants and methods of producing same |
WO2022197963A1 (en) * | 2021-03-19 | 2022-09-22 | Pfizer Inc. | Long-acting growth hormone compositions |
JP2022145646A (ja) * | 2021-03-19 | 2022-10-04 | ファイザー・インコーポレイテッド | 長時間作用型成長ホルモンポリペプチドを投与する方法 |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3421468A1 (de) | 1984-06-08 | 1985-12-19 | Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim | Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung |
EP0173552B1 (en) | 1984-08-24 | 1991-10-09 | The Upjohn Company | Recombinant dna compounds and the expression of polypeptides such as tpa |
EP0264166B1 (en) | 1986-04-09 | 1996-08-21 | Genzyme Corporation | Transgenic animals secreting desired proteins into milk |
US5118666A (en) | 1986-05-05 | 1992-06-02 | The General Hospital Corporation | Insulinotropic hormone |
US4873316A (en) | 1987-06-23 | 1989-10-10 | Biogen, Inc. | Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
ATE110571T1 (de) | 1988-05-06 | 1994-09-15 | Toray Industries | Stabile interferon-beta-zusammensetzung. |
EP0461200B1 (en) | 1989-02-21 | 1997-01-22 | Washington University | Modified forms of reproductive hormones |
ATE109507T1 (de) * | 1989-04-28 | 1994-08-15 | Miles Inc | Grossfermenter-inokulation mit gefrorenen zellen. |
US5464764A (en) | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
ES2141229T3 (es) * | 1993-04-20 | 2000-03-16 | Univ Washington | Productos farmaceuticos de proteinas y peptidos modificados. |
US5898030A (en) * | 1994-06-17 | 1999-04-27 | Applied Research Systems Ars Holding N.V | hGH containing pharmaceutical compositions |
DE19539493A1 (de) | 1995-10-24 | 1997-04-30 | Thomae Gmbh Dr K | Starker homologer Promotor aus Hamster |
KR100467751B1 (ko) * | 2001-12-03 | 2005-01-24 | 씨제이 주식회사 | 생체내 에리스로포이에틴 활성이 증진된 융합단백질 |
CN1847265A (zh) * | 2005-04-15 | 2006-10-18 | 上海市计划生育科学研究所 | 人绒毛膜促性腺激素β链羧基端37肽多聚体及用途 |
US7553941B2 (en) | 2006-02-03 | 2009-06-30 | Modigene Inc | Long-acting polypeptides and methods of producing same |
US8048849B2 (en) * | 2006-02-03 | 2011-11-01 | Modigene, Inc. | Long-acting polypeptides and methods of producing same |
US8759292B2 (en) * | 2006-02-03 | 2014-06-24 | Prolor Biotech, Llc | Long-acting coagulation factors and methods of producing same |
US20140113860A1 (en) | 2006-02-03 | 2014-04-24 | Prolor Biotech Ltd. | Long-acting polypeptides and methods of producing and administering same |
US8304386B2 (en) | 2006-02-03 | 2012-11-06 | Prolor Biotech, Inc. | Long-acting growth hormone and methods of producing same |
US8048848B2 (en) | 2006-02-03 | 2011-11-01 | Prolor Biotech Ltd. | Long-acting interferons and derivatives thereof and methods thereof |
US8476234B2 (en) * | 2006-02-03 | 2013-07-02 | Prolor Biotech Inc. | Long-acting coagulation factors and methods of producing same |
US8946155B2 (en) | 2006-02-03 | 2015-02-03 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
US9249407B2 (en) * | 2006-02-03 | 2016-02-02 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
US8450269B2 (en) | 2006-02-03 | 2013-05-28 | Prolor Biotech Ltd. | Long-acting growth hormone and methods of producing same |
KR101337797B1 (ko) * | 2010-07-14 | 2013-12-06 | 한미사이언스 주식회사 | 지속형 인간 성장 호르몬 결합체 액상 제제 |
KR20130142128A (ko) * | 2010-10-11 | 2013-12-27 | 애브비 인코포레이티드 | 단백질의 정제 방법 |
MY172539A (en) | 2012-02-14 | 2019-11-30 | Opko Biologics Ltd | Long-acting coagulation factors and methods of producing same |
WO2013152351A2 (en) * | 2012-04-06 | 2013-10-10 | The Trustees Of Columbia University In The City Of New York | Fusion polypeptides and methods of use thereof |
SG11201406671RA (en) * | 2012-04-19 | 2014-11-27 | Opko Biolog Ltd | Long-acting oxyntomodulin variants and methods of producing same |
EP2682168A1 (en) * | 2012-07-02 | 2014-01-08 | Millipore Corporation | Purification of biological molecules |
MY172997A (en) * | 2012-11-20 | 2019-12-18 | Opko Biologics Ltd | Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides |
WO2014166836A1 (en) * | 2013-04-05 | 2014-10-16 | Novo Nordisk A/S | Growth hormone compound formulation |
EP4212546A1 (en) | 2014-12-10 | 2023-07-19 | OPKO Biologics Ltd. | Methods of producing long acting ctp-modified polypeptides |
IL301728A (en) * | 2015-06-19 | 2023-05-01 | Opko Biologics Ltd | Long-term coagulation factors and methods for their preparation |
-
2015
- 2015-12-10 EP EP22209083.9A patent/EP4212546A1/en active Pending
- 2015-12-10 US US14/965,079 patent/US20160168588A1/en not_active Abandoned
- 2015-12-10 EP EP15828386.1A patent/EP3230309B1/en active Active
- 2015-12-10 AU AU2015358890A patent/AU2015358890B2/en active Active
- 2015-12-10 MX MX2017007635A patent/MX2017007635A/es unknown
- 2015-12-10 ES ES15828386T patent/ES2943359T3/es active Active
- 2015-12-10 RU RU2021103436A patent/RU2021103436A/ru unknown
- 2015-12-10 SG SG11201704706RA patent/SG11201704706RA/en unknown
- 2015-12-10 PE PE2017000987A patent/PE20171380A1/es unknown
- 2015-12-10 HR HRP20230405TT patent/HRP20230405T8/hr unknown
- 2015-12-10 MX MX2017007634A patent/MX2017007634A/es unknown
- 2015-12-10 KR KR1020207028408A patent/KR20200118505A/ko not_active Application Discontinuation
- 2015-12-10 CN CN201580073554.7A patent/CN107438623B/zh active Active
- 2015-12-10 KR KR1020177018890A patent/KR102164352B1/ko active IP Right Grant
- 2015-12-10 EP EP15867141.2A patent/EP3240564A4/en not_active Withdrawn
- 2015-12-10 KR KR1020227010215A patent/KR102527180B1/ko active IP Right Grant
- 2015-12-10 EA EA201791275A patent/EA201791275A1/ru unknown
- 2015-12-10 TW TW110139563A patent/TW202231657A/zh unknown
- 2015-12-10 NZ NZ733113A patent/NZ733113A/en unknown
- 2015-12-10 WO PCT/IL2015/051196 patent/WO2016092549A1/en active Application Filing
- 2015-12-10 WO PCT/IL2015/051197 patent/WO2016092550A2/en active Application Filing
- 2015-12-10 RU RU2017123789A patent/RU2743295C2/ru active
- 2015-12-10 PL PL15828386.1T patent/PL3230309T3/pl unknown
- 2015-12-10 US US15/533,910 patent/US20180111974A1/en active Pending
- 2015-12-10 EP EP23164376.8A patent/EP4253407A3/en active Pending
- 2015-12-10 TW TW104141620A patent/TWI746427B/zh active
- 2015-12-10 SI SI201531936T patent/SI3230309T1/sl unknown
-
2017
- 2017-06-08 IL IL252778A patent/IL252778B/en unknown
- 2017-06-08 IL IL252788A patent/IL252788B/en unknown
- 2017-06-09 PH PH12017501089A patent/PH12017501089A1/en unknown
- 2017-07-07 ZA ZA2017/04595A patent/ZA201704595B/en unknown
- 2017-07-10 CO CONC2017/0006870A patent/CO2017006870A2/es unknown
-
2018
- 2018-03-02 HK HK18103050.1A patent/HK1243444A1/zh unknown
- 2018-05-07 HK HK18105854.4A patent/HK1246322A1/zh unknown
-
2019
- 2019-05-22 AU AU2019203609A patent/AU2019203609B2/en active Active
-
2021
- 2021-02-01 US US17/164,438 patent/US20210371487A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017501089A1 (en) | Methods of producing long acting ctp-modified growth hormone polypeptides | |
MX2021008142A (es) | Metodos para cosechar cultivos de celulas de mamifero. | |
MX2020011334A (es) | Cultivo celular metabolicamente optimizado. | |
MX2016009848A (es) | Método de modulación de la galactosilación de proteína recombinante mediante optimización de medio de cultivo. | |
MX2018014043A (es) | Composiciones de cultivo celular con antioxidantes y metodos para la produccion de polipeptidos. | |
EP3633029A4 (en) | PROCESS FOR CULTURING NATURAL KILLER CELLS USING A TRANSFORMED T LYMPHOCYTE | |
SG11201901093PA (en) | Production method for insoluble recombinant protein aggregate | |
MX368656B (es) | Métodos mejorados para la producción de polipéptidos recombinantes. | |
CL2016001900A1 (es) | Sobreexpresión de los reguladores de caminos de n-glicosilación para regular la glicosilación de proteinas recombinante | |
MX2020001357A (es) | Produccion microbiana de aminas grasas. | |
EP3162892A4 (en) | Method for culturing adhesive cells, culture vessel, and method for producing protein | |
EP3587559A4 (en) | MANUFACTURING METHOD FOR ARTIFICIAL PLURIPOTENT STEM CELLS | |
MX2022003016A (es) | Metodo de produccion con iones de cobre controlados. | |
MY184391A (en) | Microorganism having improved intracellular energy level and method for producing l-amino acid using same | |
MY184625A (en) | Methods of producing long acting ctp-modified growth hormone polypeptides | |
EP3345999A4 (en) | METHOD FOR THE PRODUCTION OF INDUCED PLURIPOTENTER STEM CELLS WITH SYNTHETIC PEPTIDE | |
EP3569693A4 (en) | METHOD OF PREPARING A CELL CULTURE | |
NZ729729A (en) | Production of fully processed and functional factor x in a furin-secreting mammalian expression system | |
EP3699265A4 (en) | PROCESS FOR THE PRODUCTION OF PLURIPOTENT STEM CELLS TO DIFFERENTIATE INTO CARDIOMYOCYTES | |
MX2019006573A (es) | Optimizacion de fabricacion de gl-2045 un stradomer multimerizante. | |
EP3323894A4 (en) | Method for producing natural rubber by using recombinant microorganism | |
EP3800246A4 (en) | METHOD FOR THE PRODUCTION OF HUMAN INDUCED PLURIPOTENT STEM CELLS CONTAINING AN EXOGENOUS CHROMOSOME | |
IN2015DE00046A (es) | ||
SG11201908724VA (en) | Method for producing acetic acid | |
EP3778872A4 (en) | CELL CULTURE METHOD, METHOD FOR PRODUCING A CELL-SUPPORT COMPLEX, CULTIVATED CELL AND CELL-SUPPORT COMPLEX |